MedPath

Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone

Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone Ophthalmic Ointment, USP(Sterile)

Approved
Approval ID

10195234-e8c4-455a-9e27-0333f454ea3f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 4, 2010

Manufacturers
FDA

MWI/VetOne

DUNS: 019926120

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13985-016
Application NumberANDA064068
Product Classification
M
Marketing Category
C73584
G
Generic Name
Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateOctober 5, 2010
FDA Product Classification

INGREDIENTS (6)

NEOMYCIN SULFATEActive
Quantity: 3.5 mg in 1 g
Code: 057Y626693
Classification: ACTIB
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 g
Code: 19371312D4
Classification: ACTIB
BACITRACIN ZINCActive
Quantity: 400 [USP'U] in 1 g
Code: 89Y4M234ES
Classification: ACTIB
HYDROCORTISONEActive
Quantity: 10 mg in 1 g
Code: WI4X0X7BPJ
Classification: ACTIB
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone - FDA Drug Approval Details